← FDA Drug Approvals (Drugs@FDA)

MICAFUNGIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-10-24

Drug application

FDA Application #

ANDA215241

Application type

Abbreviated New Drug Application (Generic)

Brand name

MICAFUNGIN SODIUM

Generic name

MICAFUNGIN

Active ingredients

MICAFUNGIN SODIUM

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ZYDUS PHARMS

Manufacturer

Zydus Pharmaceuticals USA Inc.

First approval

2022-10-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown